Cascara sagrada/magnesium hydroxide Interactions
There are 418 drugs known to interact with cascara sagrada/magnesium hydroxide, along with 5 disease interactions. Of the total drug interactions, 13 are major, 334 are moderate, and 71 are minor.
- View all 418 medications that may interact with cascara sagrada/magnesium hydroxide
- View cascara sagrada/magnesium hydroxide disease interactions (5)
Most frequently checked interactions
View interaction reports for cascara sagrada / magnesium hydroxide and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- Advair HFA (fluticasone / salmeterol)
- Ambien (zolpidem)
- Azithromycin Dose Pack (azithromycin)
- Bayer Aspirin (aspirin)
- Benadryl Allergy (diphenhydramine)
- Calan SR (verapamil)
- Calcium 600 D (calcium / vitamin d)
- Calcium Liquid Softgel (calcium carbonate)
- Colace (docusate)
- Coricidin HBP Cold & Flu (acetaminophen / chlorpheniramine)
- Crestor (rosuvastatin)
- Dulcolax Laxative (bisacodyl)
- Emergen-C (multivitamin with minerals)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flexeril (cyclobenzaprine)
- Hydrocodone CP (chlorpheniramine / hydrocodone / phenylephrine)
- Incruse Ellipta (umeclidinium)
- Keppra (levetiracetam)
- Klor-Con (potassium chloride)
- MethylPREDNISolone Dose Pack (methylprednisolone)
- Mobic (meloxicam)
- Nitro Macro (nitrofurantoin)
- One Daily with Minerals (multivitamin with minerals)
- Pepcid (famotidine)
- Plaquenil (hydroxychloroquine)
- Proventil (albuterol)
- Restasis (cyclosporine ophthalmic)
- Rheumate (multivitamin)
- Symbicort (budesonide / formoterol)
Cascara sagrada/magnesium hydroxide disease interactions
There are 5 disease interactions with cascara sagrada / magnesium hydroxide which include:
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
- acute surgical abdomen
- rectal bleeding
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.